IMCD Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
5,237
- Stock Symbol
-
IMCD
- Investments
-
111
- Share Price
-
$111.43
- (As of Friday Closing)
IMCD General Information
Description
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
Contact Information
Website
www.imcdgroup.comCorporate Office
- Wilhelminaplein 32
- 3072 DE Rotterdam
- Netherlands
Corporate Office
- Wilhelminaplein 32
- 3072 DE Rotterdam
- Netherlands
IMCD Stock Performance
As of 20-Nov-2026, IMCD’s stock price is $111.43. Its current market cap is $6.58B with 59M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $111.43 | $116.68 | $78.88 - $122.74 | $6.58B | 59M | 133K | $4.54 |
IMCD Financials Summary
As of 30-Jun-2026, IMCD has a trailing 12-month revenue of $5.77B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 7,020,372 | 6,758,142 | 9,879,288 | 10,580,485 |
| Revenue | 5,766,877 | 5,390,599 | 5,115,733 | 4,807,274 |
| EBITDA | 617,164 | 562,940 | 631,374 | 609,752 |
| Net Income | 268,541 | 245,429 | 301,086 | 316,259 |
| Total Assets | 5,646,738 | 5,445,383 | 5,076,181 | 4,592,466 |
| Total Debt | 1,654,881 | 2,019,508 | 1,764,448 | 1,318,457 |
IMCD Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
IMCD Comparisons
Industry
Financing
Details
IMCD Competitors (6)
One of IMCD’s 6 competitors is Azelis Group, a Formerly PE-Backed company based in Berchem, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Azelis Group | Formerly PE-Backed | Berchem, Belgium | ||||
| Brenntag | Formerly PE-Backed | Essen, Germany | ||||
| Brenntag UK Holding | Corporation | Leeds, United Kingdom | ||||
| Univar Solutions | Private Equity-Backed | Downers Grove, IL | ||||
| Parchem Fine and Specialty Chemicals | Corporation | New Rochelle, NY |
IMCD Signals
IMCD Investments & Acquisitions (111)
IMCD’s most recent deal was a Merger/Acquisition with Merit Solution. The deal was made on 29-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Merit Solution | 29-Jun-2026 | Merger/Acquisition | Distributors/Wholesale | ||
| Willows Ingredients | 19-Mar-2026 | Merger/Acquisition | Distributors/Wholesale | ||
| Dong Yang FT | 15-Jan-2026 | Merger/Acquisition | Distributors/Wholesale | ||
| Tillmanns | 09-Dec-2025 | Merger/Acquisition | Specialty Chemicals | ||
| Valuetree Ingredients | 07-Aug-2025 | Secondary Transaction - Private | Distributors/Wholesale |
IMCD ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
11.06 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Traders & Distributors
Industry
of 158
Rank
Percentile
Trading and Distribution
Subindustry
of 158
Rank
Percentile
IMCD Exits (2)
IMCD’s most recent exit was on 12-Nov-2012 from Hatch Küttner. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Hatch Küttner | 12-Nov-2012 | Completed |
|
||
| Nutri Granulations | Merger/Acquisition | Completed |
IMCD Affiliates
Subsidiaries (40)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| O&3 | Ripon, United Kingdom | 2018 | |
| Apus Química | San Bernardo, Chile | 2016 | |
| Imcd Finance | Rotterdam, Netherlands | 2011 | |
| Cobapharma | Barcelona, Spain | 2011 | |
| Internatio Special Products | Rotterdam, Netherlands | 2010 |
IMCD FAQs
-
When was IMCD founded?
IMCD was founded in 1995.
-
Where is IMCD headquartered?
IMCD is headquartered in Rotterdam, Netherlands.
-
What is the size of IMCD?
IMCD has 5,237 total employees.
-
What industry is IMCD in?
IMCD’s primary industry is Specialty Chemicals.
-
Is IMCD a private or public company?
IMCD is a Public company.
-
What is IMCD’s stock symbol?
The ticker symbol for IMCD is IMCD.
-
What is the current stock price of IMCD?
As of 20-Nov-2026 the stock price of IMCD is $111.43.
-
What is the current market cap of IMCD?
The current market capitalization of IMCD is $6.58B.
-
What is IMCD’s current revenue?
The trailing twelve month revenue for IMCD is $5.77B.
-
Who are IMCD’s competitors?
Azelis Group, Brenntag, Brenntag UK Holding, Univar Solutions, and Parchem Fine and Specialty Chemicals are some of the 6 competitors of IMCD.
-
What is IMCD’s annual earnings per share (EPS)?
IMCD’s EPS for 12 months was $4.54.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process